Elexacaftor

CHEMBL4298128 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
597.7 g/mol
LogP
4.9
Phase
4

This medication works by correcting the misfolded CFTR protein that causes cystic fibrosis, helping it function more normally in the lungs. It is used in combination with other CFTR modulators for greater benefit.

Molecular Weight

597.7000 g/mol

LogP

4.90

TPSA

133.00 Ų

Lipinski RO5

Fail

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1nn(C)cc1S(=O)(=O)NC(=O)c1ccc(-n2ccc(OCC(C)(C)C(F)(F)F)n2)nc1N1C[C@@H](C)CC1(C)C

InChI

InChI=1S/C26H34F3N7O4S/c1-16-12-25(5,6)35(13-16)22-18(23(37)33-41(38,39)19-14-34(7)31-17(19)2)8-9-20(30-22)36-11-10-21(32-36)40-15-24(3,4)26(27,28)29/h8-11,14,16H,12-13,15H2,1-7H3,(H,33,37)/t16-/m0/s1

Molecular Formula

C26H34F3N7O4S

HBD / HBA

1 / 11

Rotatable Bonds

8

Heavy Atoms

41

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

This medication works by correcting the misfolded CFTR protein that causes cystic fibrosis, helping it function more normally in the lungs. It is used in combination with other CFTR modulators for greater benefit.

Yes, Elexacaftor is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4298128. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 134587348. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.